Eli Lilly | LLY - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Abbott USD 6.99B 501M 2026-03
ALKERMES USD 298.96M 37.75M 2026-06
Amgen USD 6.22B 34M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Baxter International USD 2.26B 57M 2026-06
Biogen USD 2.38B 435.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Coherus Biosciences USD 5.67M 842K 2026-06
Drreddys Laboratories INR 76.53B 2.48B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
J&J USD 15.14B 561M 2026-06
Medtronic USD 5.95B 358M 2026-03
Merck USD 6.21B 272M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Novartis USD 6.29B 135M 2026-03
Novo Nordisk DKK 45.65B 21.26B 2025-06
Perrigo USD 1.06B 56.9M 2026-06
Pfizer USD 9.94B 722M 2026-06
Phibro Animal Health USD 534.88M 4.82M 2026-06
Prestige Brands USD 190.22M 31.08M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
Sanofi EUR 23.5B 812M 2026-03
United Therapeutics USD 193.8M 15.5M 2026-06
Zoetis USD 2.57B 24M 2026-06